INO

#3279
Inovio Pharmaceuticals, Inc.
1.81
+1.12%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
1.81
1.81
Jahresspanne
1.30
2.98
Tagesänderung
+1.12%
Monatliche Änderung
+19.08%
6 month change
-27.60%
Jahresänderung
-6.70%
Vorheriger Schlusskurs
1.79
Open
1.81
Bid
Ask
Low
1.81
High
1.81
Volumen
20
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 94.43 M
  • Employee 134
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.46
Price to sales ratio
228.26
Dividends per share
—
Dividend yield %
—

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Nachrichten